An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway
- PMID: 1784339
- DOI: 10.1007/BF00965839
An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway
Abstract
Two enzymes have been found which catalyze the initial step in the catabolism of GHB. The oxidation of GHB to SSA, catalyzed by both of these enzymes, is coupled to the reduction of an oxoacid. In the case of the mitochondrial transhydrogenase, the coupling is obligatory. Although coupling is not obligatory for the GHB dehydrogenase, the stimulation provided by the coupled reaction, and the nature of the kinetics of the uncoupled reaction, may not only allow the reaction to proceed, but may provide a means of regulating the rate of the reaction under in vivo conditions. Since the oxidation of GHB to SSA is the rate limiting step in the overall catabolic pathway (the rate of conversion of GHB to SSA proceeds at approximately one one thousandth of the rate at which SSA is oxidized to succinate by SSA dehydrogenase (30)), factors which regulate the rate of either or both of these enzymes will, in turn, influence tissue levels of endogenous GHB as well as the duration and magnitude of the physiological effect of a dose of GHB.
Similar articles
-
Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme.J Neurochem. 1988 Oct;51(4):1079-84. doi: 10.1111/j.1471-4159.1988.tb03071.x. J Neurochem. 1988. PMID: 3138385
-
Developmental time courses in the brain and kidney of two enzymes that oxidize gamma-hydroxybutyrate.Dev Neurosci. 1994;16(5-6):352-8. doi: 10.1159/000112129. Dev Neurosci. 1994. PMID: 7768215
-
Evidence for a role of high Km aldehyde reductase in the degradation of endogenous gamma-hydroxybutyrate from rat brain.FEBS Lett. 1985 Oct 7;190(1):55-60. doi: 10.1016/0014-5793(85)80426-9. FEBS Lett. 1985. PMID: 3899725
-
Significance of gamma-hydroxybutyric acid in the brain.Gen Pharmacol. 1992 Nov;23(6):1027-34. doi: 10.1016/0306-3623(92)90282-o. Gen Pharmacol. 1992. PMID: 1487112 Review.
-
Enzymology of the alternative reductive pathway of GABA catabolism leading to the biosynthesis of gamma-hydroxybutyrate.Adv Biochem Psychopharmacol. 1981;29:527-35. Adv Biochem Psychopharmacol. 1981. PMID: 7020369 Review. No abstract available.
Cited by
-
Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs.J Biol Chem. 2009 Nov 27;284(48):33521-34. doi: 10.1074/jbc.M109.055665. Epub 2009 Sep 15. J Biol Chem. 2009. PMID: 19759021 Free PMC article.
-
Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate.J Biol Chem. 2011 Feb 18;286(7):5895-904. doi: 10.1074/jbc.M110.196808. Epub 2010 Dec 1. J Biol Chem. 2011. PMID: 21126961 Free PMC article.
-
Diversity and Evolutionary Analysis of Iron-Containing (Type-III) Alcohol Dehydrogenases in Eukaryotes.PLoS One. 2016 Nov 28;11(11):e0166851. doi: 10.1371/journal.pone.0166851. eCollection 2016. PLoS One. 2016. PMID: 27893862 Free PMC article.
-
Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.J Pharm Sci. 2014 Oct;103(10):3310-5. doi: 10.1002/jps.24122. Epub 2014 Aug 29. J Pharm Sci. 2014. PMID: 25174723 Free PMC article.
-
Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.J Pharmacol Exp Ther. 2013 Apr;345(1):102-10. doi: 10.1124/jpet.112.202796. Epub 2013 Feb 7. J Pharmacol Exp Ther. 2013. PMID: 23392755 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials